PDS Biotechnology Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2013 | $-8.0M | $-8.2M | $136.9K | $260.4K |
| FY2014 | $-9.7M | $-10.6M | $884.8K | $1.3M |
| FY2015 | $-21.8M | $-23.1M | $1.3M | $2.9M |
| FY2016 | $-32.2M | $-32.9M | $686.7K | $5.3M |
| FY2017 | $-40.7M | $-40.9M | $188.7K | $6.2M |
| FY2018 | $-1.6M | $-1.6M | $0 | $866.8K |
| FY2019 | $-18.1M | $-18.1M | — | $3.1M |
| FY2020 | $-13.1M | $-13.1M | — | $432.3K |
| FY2021 | $-12.5M | $-12.5M | — | $4.1M |
| FY2022 | $-25.7M | $-25.7M | — | $5.2M |
| FY2023 | $-33.6M | $-33.6M | $0 | $7.6M |
| FY2024 | $-35.0M | $-35.1M | $29.0K | $6.8M |
| FY2025 | $-27.8M | $-27.8M | $0 | $4.1M |